We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Warby Parker
WRBY
$3.31B
| $3.13M | 0.03% |
230,108
+123,142
| +115% | +$1.63M |
|
402
First Advantage
FA
$4.14B
| $3.11M | 0.03% |
+191,884
| New | +$3.13M |
|
403
Regenxbio
RGNX
$722M
| $3.08M | 0.03% |
+146,334
| New | +$2.6M |
|
404
BellRing Brands
BRBR
$1.41B
| $2.94M | 0.03% |
+49,871
| New | +$2.84M |
|
405
American Airlines Group
AAL
$10.6B
| $2.91M | 0.03% |
+189,703
| New | +$2.75M |
|
|
RAPT
406
DELISTED
RAPT Therapeutics
RAPT
| $2.89M | 0.03% |
40,202
+15,052
| +60% | +$2.09M |
|
407
Flex
FLEX
$45.3B
| $2.85M | 0.03% |
99,479
-785,864
| -89% | -$20.6M |
|
408
Semtech
SMTC
$12.6B
| $2.81M | 0.03% |
102,052
+8,470
| +9% | +$181K |
|
409
Voyager Therapeutics
VYGR
$189M
| $2.79M | 0.03% |
+300,000
| New | +$2.53M |
|
|
HA
410
PUT
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.67M | 0.02% |
200,000
| – | – |
|
411
Vor Biopharma
VOR
$1.28B
| $2.63M | 0.02% |
55,556
| – | – |
|
412
Aquestive Therapeutics
AQST
$492M
| $2.56M | 0.02% |
+600,592
| New | +$2M |
|
413
Sweetgreen
SG
$698M
| $2.52M | 0.02% |
+99,848
| New | +$1.45M |
|
414
Aurinia Pharmaceuticals
AUPH
$2.07B
| $2.51M | 0.02% |
500,555
-144,639
| -22% | -$981K |
|
415
Zurn Elkay Water Solutions
ZWS
$8.6B
| $2.48M | 0.02% |
+74,056
| New | +$2.28M |
|
416
Perrigo
PRGO
$1.74B
| $2.44M | 0.02% |
75,819
| – | – |
|
417
Progress Software
PRGS
$1.71B
| $2.43M | 0.02% |
45,575
-23,333
| -34% | -$1.28M |
|
418
BBB Foods
TBBB
$4.9B
| $2.43M | 0.02% |
+102,077
| New | +$2.19M |
|
419
Replimune Group
REPL
$1.08B
| $2.4M | 0.02% |
293,622
| – | – |
|
420
Relay Therapeutics
RLAY
$4.3B
| $2.27M | 0.02% |
273,008
+23,008
| +9% | +$224K |
|
421
EverCommerce
EVCM
$1.88B
| $2.24M | 0.02% |
237,885
-31,087
| -12% | -$303K |
|
422
Altimmune
ALT
$585M
| $2.18M | 0.02% |
+214,245
| New | +$2.18M |
|
423
iShares MSCI Brazil ETF
EWZ
$9.07B
| $2.06M | 0.02% |
+63,690
| New | +$2.11M |
|
|
SAGE
424
DELISTED
Sage Therapeutics
SAGE
| $1.96M | 0.02% |
+104,831
| New | +$2.42M |
|
425
Trade Desk
TTD
$8.31B
| $1.94M | 0.02% |
22,232
-3,513
| -14% | -$266K |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.